Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis (KDSKOA)

U

University of Primorska

Status

Not yet enrolling

Conditions

Osteoarthritis, Knee

Treatments

Other: Training Placebo Dietary Supplement (G2)
Other: Non-training Real Dietary Supplement (G1)
Other: Training Real Dietary Supplement (G3)

Study type

Interventional

Funder types

Other

Identifiers

NCT06269549
KDS_KOA

Details and patient eligibility

About

The goal of this clinical trial is to assess the effectiveness of dietary supplement combined with exercise in managing knee osteoarthritis (KOA). The main questions it aims to answer are: Is adding a dietary supplement to exercise additionally effective in managing KOA? Is adding exercise to the dietary supplement additionally effective in managing KOA? Participants will be given in three groups: Real dietary supplement alone Real dietary supplement with exercise Placebo dietary supplement with exercise Investigators will compare groups 1 and 2, or 2 and 3, to answer the research questions. The hypothesis is that participants who receive the dietary supplement along with exercise will experience greater reduction in pain level, improved physical function, and enhanced quality of life compared to those who receive a placebo combined with exercise or dietary supplement alone.

Full description

Participant recruitment will take place at the Community Healthcare Center dr. Adolf Drolc Maribor based on the doctor's recommendation. Following an informed discussion about the study and potential risks, all patients providing written consent will undergo a one-week screening period to determine eligibility for study entry. Upon reaching week 0, patients meeting the eligibility criteria will be randomly assigned in a 1:1:1 ratio to receive either dietary supplements alone, dietary supplements combined with exercise, or placebo dietary supplement combined with exercise. The effects of the kinesiological / dietary supplement intervention on selected measures will be assessed using a test battery, before and after the 12 week intervention. Exercise / test batery will be conducted at Community Healthcare Center dr. Adolf Drolc under the supervision of an experienced kinesiologist / investigator. Based on the posed research questions and hypotheses, investigators would like to highlight the following planned statistical analyses. In the case of bilateral KOA, investigators will analyze the more affected knee for differences between groups. In addition to descriptive statistics, investigators will assess normal distribution and homogeneity of variances. Differences between groups will be tested using two-way repeated measures analysis of variance (factor 1 = group, factor 2 = time) and paired two-tailed post-hoc t-tests with Bonferroni correction. The main comparison will be addressed with a 3x2 two-way analysis of variance. The first research question will be addressed with a 2x2 two-way analysis of variance, including groups 2 and 3. The second research question will be addressed with a two-way analysis of variance, including groups 1 and 2. Additionally, effect size will be calculated. The level of statistical significance will be set at p<0.05.

Enrollment

120 estimated patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • knee osteoarthritis of one or both knee
  • severity of knee osteoarthritis based on Kellgren-Lawrence radiographic grade 1-3

Exclusion criteria

  • Age <55 years
  • Kellgren & Lawrence grade 4 of knee osteoarthritis
  • Acute knee injuries within the last 6 months
  • Knee pain not associated with knee osteoarthritis
  • History of knee or hip endoprosthesis
  • Surgery on the back, hip, knee, ankle, or foot within the last 12 months
  • Health issues or musculoskeletal limitations affecting strength training and mobility more than knee pain (e.g., lower back pain, hip pain)
  • Neurological conditions (Alzheimer's disease, Parkinson's disease, metabolic diseases affecting the nervous system)
  • Muscular or joint diseases/injuries affecting lower limb function (e.g., hip and/or ankle osteoarthritis, sprains, fractures)
  • Internal medical conditions (cardiovascular, pulmonary, oncological, diabetes with late complications - diabetic foot, neuropathies) affecting physical performance
  • Stroke or similar condition with consequences on motor skills and/or cognition (inability to provide consent)
  • Balance disorders, known vestibular system impairment
  • Body Mass Index > 32
  • Structured strength training exceeding 30 minutes per week
  • Corticosteroids and/or hyaluronic acid (intra-articular) use in the last 3 months
  • Individuals taking joint health dietary supplements, like glucosamine, chondroitin, or collagen, will need to halt use for at least 14 days before measurements to avoid affecting study outcomes

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

120 participants in 2 patient groups

The effect of dietary supplements added to physical exercise intervention
Other group
Description:
This study arm will include two groups of participants, one receiving 12 weeks physical exercise intervention together with real dietary supplements (Active Joint, and Collagen Powder Blend), while the other group receiving exercise intervention with placebo dietary supplements (placebo Active Joint and placebo Collagen Powder Blend).
Treatment:
Other: Training Real Dietary Supplement (G3)
Other: Training Placebo Dietary Supplement (G2)
The effect of physical exercise added to dietary supplement intervention
Other group
Description:
This study arm will include two groups of participants, one receiving 12 weeks real dietary supplements alone (Active Joint, and Collagen Powder Blend), while the other group receiving real dietary supplements (Active Joint and Collagen Powder Blend) with physical exercise.
Treatment:
Other: Training Real Dietary Supplement (G3)
Other: Non-training Real Dietary Supplement (G1)

Trial contacts and locations

2

Loading...

Central trial contact

Nejc Šarabon, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems